| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | 0.12 | 2e-05 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.14 | 4e-05 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.21 | 5e-05 |
| mRNA | NSC-207895 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.12 | 8e-05 |